On 11 March 2026, the Supreme Court of India allowed the withdrawal of life-sustaining treatment in Harish Rana v. Union of India (hereinafter “Harish Rana”), the first case applying the framework set out in Common Cause v. Union of India (hereinafter “Common Cause”) and its 2023 procedural modification. In its decision, the Court held that Clinically Assisted Nutrition and Hydration (CANH) was a form of “medical treatment”, expanded on the scope of the “best interests” standard, and ultimately ordered the discontinuation of CANH for a patient who had been in a Persistent Vegetative State (PVS) for a prolonged period of over thirteen years.

While this judgment is a remarkably progressive step that advances the right to die with dignity, the reasoning employed by the 2-Judge Bench of the Court (totaling 338 pages) raises some concerns about the manner in which non-voluntary decisions to withdraw treatment would be made, and whose idea of dignity would be considered to be paramount.

The Court’s acceptance of non-voluntary passive euthanasia through a best-interests paradigm might seem to be normatively attractive in certain hard cases, but it ultimately risks undermining patient autonomy and leading to ableist assumptions in the absence of a more demanding, procedurally sound account of substituted judgment and safeguards. Furthermore, by persuading the Parliament once again to propose relevant legislation while also significantly distilling the guidelines laid down in Common Cause, the Court creates an unstable dichotomy between standards crafted by the judiciary and the vacuum left by legislative inaction.

The Supreme Court’s Decision

The petitioner, Harish Rana, suffered a diffuse axonal brain injury in 2013, which was caused after a fall from the fourth floor of his accommodation, during the course of pursuing his undergraduate degree. This resulted in him suffering from quadriplegia and 100 percent disability. He was put under Clinically Assisted Nutrition and Hydration (CANH) treatment, which became his primary form of consumption of food and hydration, through a Percutaneous Endoscopic Gastrostomy Tube (PEG) tube. Subsequent medical reports noted that Harish displayed no evidence of being spatially aware of his environment, nor had he demonstrated the ability to improve engagement in meaningful interactions, for over a decade.

While adhering to the guidelines in Common Cause, the Court initially directed the creation of a primary medical board by the Chief Medical Officer, and subsequently, a secondary board was established at the All-India Institute of Medical Sciences (AIIMS). Both of these boards came to the conclusion that Harish had suffered “irreversible brain damage” which fulfilled the criteria for permanent PVS, and that CANH was necessary for his mere biological sustenance, but would be unable to improve his underlying ailment. After considering these reports, the Court directed a structured joint interaction amongst the lawyers and the family of the petitioner. The joint report noted that Harish’s family, after thirteen years of intensive care at home, were of the opinion that continuing CANH would simply prolong his suffering and that it would go against his wishes to continue to exist in this state.

Based on this, the Bench held that CANH constitutes “medical treatment” and upon applying the guidelines postulated in Common Cause “in their full measure”, ordered the discontinuation of all life-sustaining treatment for Harish. This is particularly important considering that in Common Cause, the Court legalized the withdrawal of “medical treatment” in certain circumstances i.e., it did not permit the starvation or neglect of patients by discontinuing basic care. By holding that CANH falls within the purview of “medical treatment” and not “mere sustenance”, the Court paved the way for legal withdrawal to be categorized as a permitted omission, and not unlawful starvation or neglect. Essentially, if CANH had been recognized as a form of “basic care”, its discontinuation would be perceived as an impermissible abandonment. Since it has been recognized as a form of “medical treatment”, its withdrawal or continuation places it within the purview of the framework recognized in Common Cause. This directive issued by the Court was to be accompanied by a robust palliative and end‑of‑life (EOL) care plan at AIIMS. The Court waived the usual reconsideration period of thirty days, directed admission of the applicant to AIIMS’s palliative care department, and issued further directions to streamline medical boards and judicial oversight at the level of Judicial Magistrates of First Class.

Recasting CANH as Medical Treatment

A central aspect of the judgment is the insistence that CANH is not mere “basic care” but a technologically mediated medical intervention that must be subject to the same ethical and legal principles governing other life‑sustaining treatments. The Court emphasises that all forms of enteral and parenteral nutrition administered on clinical indication, especially via PEG tubes and similar devices, are prescribed, supervised, and periodically reviewed by trained professionals, and that to treat them as non‑medical would deprive doctors of the agency needed to assess their therapeutic value. Doctrinally, this move is sound and arguably overdue. It aligns Indian law with comparative jurisprudence, particularly in the United Kingdom, where withdrawal of artificial nutrition and hydration in PVS cases has long been treated as a decision about medical treatment rather than abandonment of basic care. It also prevents an artificial distinction that would have made the Common Cause framework inapplicable to one of the most common modalities through which life is prolonged in PVS and minimally conscious states.

Yet, the judgment could have more clearly articulated how this reclassification interfaces with the broader duty of care owed by the State and families towards persons with severe disabilities. A more explicit acknowledgment that withdrawal decisions must be tightly tied to the patient’s consciousness, prognosis, and expressed or inferred values, rather than the mere presence of medical technology, would have strengthened the doctrinal boundary between disability‑affirming care and end‑of‑life decision‑making.

Best Interests and Substituted Judgment

The Court devotes a large portion of the judgment to elaborating the principle of the “best interest of the patient”, drawing heavily on foreign jurisprudence from the United States, the United Kingdom, Ireland, Italy, Australia, New Zealand, and the European Union.
It constructs a multi‑factor, holistic test that requires decision‑makers to evaluate not only strictly medical considerations such as futility and burden of treatment, but also non‑medical factors including the patient’s past and present wishes, values, relationships, and overall welfare in the “widest sense”.

In doing so, the Court explicitly incorporates a “strong element” of the substituted‑judgment standard. Decision‑makers, whether relatives, doctors, boards, or courts, are instructed to place themselves, as far as possible, in the position of the patient and ask what that patient would have wanted if competent, while still ultimately grounding the inquiry in an objective assessment of best interests. The judgment requires a “balance‑sheet exercise” weighing potential benefits of continued treatment against burdens such as pain, invasiveness, indignity, and the impact on the patient’s and family’s lived experience.

This synthesis of best interests and substituted judgment is attractive because it resists both a purely paternalistic standard and a purely formalistic deference to past autonomy that ignores radically changed circumstances. However, the doctrinal architecture remains under‑specified at precisely the points where abuses are most likely. The judgment does not lay down clear evidentiary thresholds or hierarchy among factors. Nor does the Court engage deeply with the risk that family members’ own exhaustion, grief, or economic constraints may, understandably, shape perceptions of futility and indignity, especially over protracted periods of home care. The joint report in Harish Rana movingly records the parents’ love and long struggle, but the Court treats their wishes as essentially convergent with the applicant’s inferred will without asking whether independent psychological or social‑work assessments should form part of the evidentiary matrix in passive euthanasia cases. Future cases may not involve such evidently caring families, and a more demanding framework would have been desirable.

Dignity, Disability, and Non‑Voluntary Euthanasia

Building on Common Cause, this judgment locates the permissibility of withdrawing life‑sustaining treatment within Article 21’s guarantee of the right to live, and die, with dignity, read together with self‑determination, bodily autonomy, and privacy. It explicitly acknowledges non‑voluntary passive euthanasia, recognising that unconscious or incompetent patients retain a right to bodily integrity and that authorised omissions by doctors, when treatment is futile and burdensome, can be consistent with their duty of care. The rhetoric of dignity is powerful as the Court warns against condemning a person to an “undignified state” where life is measured only by artificial heartbeats, with no awareness, memories, or future hopes. In Harish Rana’s case, this language resonates with the medical evidence of permanent PVS and the family’s testimony that the applicant has had no meaningful response for thirteen years.

Yet dignity talk is a double‑edged sword, particularly in a jurisdiction where persons with disabilities have long struggled against stereotypes that equate severe impairment with a life not worth living. The Court does not substantially engage with the disability rights framework under the Rights of Persons with Disabilities Act and the UN Convention on the Rights of Persons with Disabilities, nor does it articulate how to prevent slippage from “dignified death” in PVS to “undignified life” in conditions of profound but conscious disability.

The risk is that the dignitarian vocabulary, coupled with a capacious best‑interests test, might inadvertently validate ableist intuitions about whose suffering counts and when continued existence is “futile”. A disability‑sensitive approach would have benefited from clearer markers. For instance, insisting that non‑voluntary withdrawal decisions be confined to cases of permanent absence of consciousness or responsive awareness established by rigorous clinical criteria, and that courts explicitly distinguish such cases from those involving severe but conscious impairment.

Institutional Design and Legislative Inaction

The judgment is also an important intervention in institutional design. It streamlines the Common Cause guidelines by clarifying the role of primary and secondary medical boards, expanding the pool of eligible specialists, providing for home‑care situations, and assigning a limited, largely notificatory role to Judicial Magistrates of First Class where both boards agree on withdrawal. These adjustments respond to concerns that the original guidelines were too cumbersome and ill‑suited to India’s overburdened public health system. At the same time, the Court laments persistent legislative inaction despite multiple prior Law Commission reports, the earlier Aruna Shanbaug decision, and Common Cause itself, and calls for a comprehensive statutory framework on end‑of‑life care and euthanasia.

This judgment thus fits into a broader pattern of transformative but piecemeal constitutional adjudication in India, in which ambitious rights reasoning coexists uneasily with the absence of democratically enacted framework statutes. The difficulty is that, in the meantime, the Court’s own guidelines and doctrinal refinements function as de facto legislation, shaping medical practice and patients’ lives nationwide. Given this reality, the Court might have been more candid about the normative choices embedded in its framework and more willing to concretise certain safeguards instead of leaving them to future legislation.

Concluding thoughts

The Harish Rana judgment is, in many respects, a humane and carefully reasoned attempt to apply the Common Cause architecture to a paradigmatic hard case of end‑of‑life decision‑making. It brings much‑needed clarity to the status of CANH, develops a nuanced best‑interests standard, and highlights the importance of palliative and EOL care as an inseparable component of the right to die with dignity. Yet its embrace of non‑voluntary passive euthanasia through a broadly framed best‑interests inquiry leaves important questions about autonomy, disability, and institutional safeguards insufficiently addressed.

For future cases and, crucially, for any forthcoming legislation, three moves appear particularly important. First, a clearer hierarchy between the presumption in favour of life and the substituted‑judgment component of best interests is needed, with specified evidentiary thresholds for inferring a patient’s will in the absence of an Advance Medical Directive.
Second, disability‑rights perspectives must be integrated more explicitly – both in defining the class of cases in which withdrawal is permissible and in training decision‑makers to distinguish between dignified disability and genuinely futile continuation of treatment in states of permanent unconsciousness.

Third, institutional safeguards around medical boards and family decision‑making require strengthening through independent psychosocial assessments and periodic review.

Without such refinements, the laudable aspiration to secure a dignified death risks shading into an unarticulated hierarchy of dignified lives. The Supreme Court has taken a decisive, and in many ways courageous, step by permitting passive euthanasia in this first concrete application of Common Cause; the challenge now is to ensure that the doctrinal and institutional architecture built around this step is capable of protecting, rather than silently narrowing, the autonomy and dignity of those who can no longer speak for themselves.